Supplementary data B Any reported adverse event that occurred in less than 5% of any group – grouped under the primary System Organ Class, according to the MedDRA coding system.
Osteoporosis (OP) is a common skeletal disorder characterized by decreased bone mass and increased fracture risk. Anabolic agents such as teriparatide (TP) and abaloparatide (ABL) have been introduced
